## LULU: lululemon athletica inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 1.1% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($175.38)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Amundi Has $105.45 Million Stock Position in lululemon athletica inc. $LULU**
- Source: MarketBeat | 20251208T080843 | Neutral | Relevance: 100%
-  Amundi significantly reduced its stake in lululemon athletica (NASDAQ:LULU) by 31.6% in the second quarter, now holding 428,140 shares valued at approximately $105.45 million, representing about 0.36% of the company. Despite mixed analyst sentiment with a consensus "Hold" rating and a target price of $221.22, the company recently beat EPS expectations with quarterly earnings of $3.10 against an estimated $2.86. Lululemon Athletica Inc. (NASDAQ:LULU) has a market capitalization of $22.53 billion and trades within a 12-month range of $159.25 to $423.32.

**2. L2 Asset Management LLC Purchases Shares of 6,873 lululemon athletica inc. $LULU**
- Source: MarketBeat | 20251208T122925 | Neutral | Relevance: 99%
- L2 Asset Management LLC has acquired a new stake of 6,873 shares in lululemon athletica inc., valued at approximately $1.63 million, making institutional investors now own 85.20% of the company. Despite beating EPS expectations, lululemon slightly missed revenue forecasts, though it demonstrated strong profitability. Analyst sentiment for LULU is largely neutral with an average "Hold" rating and a consensus price target of $221.22.

**3. Vision Capital Fundâ€™s Views on Lululemon (LULU)**
- Source: Insider Monkey | 20251209T083900 | Neutral | Relevance: 99%
-  Vision Capital Fund shared its views on Lululemon Athletica Inc. (NASDAQ: LULU) in its Q3 2025 investor letter, noting weak earnings in Q1 and Q2 2025 due to headwinds in the US market and inventory issues. Despite strong growth in China, the fund suggests that while Lululemon is outperforming competitors like Nike, AI stocks might offer greater returns. Lululemon is not among their top 30 most popular stocks for hedge funds.

**4. Lululemon (LULU) Q3 Earnings: What To Expect**
- Source: Finviz | 20251210T032846 | Neutral | Relevance: 98%
-  Lululemon (LULU) will report its Q3 earnings this Thursday afternoon, with analysts expecting a 3.3% year-on-year revenue growth to $2.48 billion and adjusted earnings of $2.21 per share. The company missed revenue expectations last quarter, and its full-year EPS guidance fell short of analyst estimates. Competitors like Zumiez and American Eagle have shown positive Q3 results, and investor sentiment in the apparel retailer sector is currently positive.

**5. lululemon Pre-Q3 Earnings: Is it Wise to Buy Amid Evolving Headwinds?**
- Source: TradingView | 20251208T180843 | Neutral | Relevance: 98%
- lululemon (LULU) is expected to report its Q3 fiscal 2025 earnings on December 11, facing headwinds such as softening demand in North America, particularly the U.S., and increased tariffs impacting gross margins. Despite these challenges, the company's international markets, especially Mainland China, show strong momentum, driven by its Power of Three x2 growth plan. While near-term profitability faces pressure, the long-term strategy focuses on global expansion, men's business growth, and digital engagement, offering a basis for existing shareholders to stay invested, but suggesting caution for new investors looking for clearer signs of stabilization.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Guggenheim | $0 | $0 | 0% |
| 2025-12-08 | Telsey Advisory | $200 | $200 | 0% |
| 2025-11-25 | BTIG | $303 | $303 | 0% |
| 2025-11-18 | Goldman Sachs | $180 | $200 | -10% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Guggenheim | init | Neutral |
| 2025-12-08 | Telsey Advisory | main | Market Perform |
| 2025-11-25 | BTIG | reit | Buy |
| 2025-11-18 | Goldman Sachs | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 1 ($0.11M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+3.9%)
- Blackrock Inc.: 8.8% (-0.9%)
- State Street Corpora: 4.1% (-1.1%)
- FMR, LLC: 3.6% (-65.8%)
- Geode Capital Manage: 2.6% (+0.6%)

### Key Risks

1. Elevated short interest (8.0%): bears positioning against stock.
2. Long-term trend broken: trading 19.4% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.90 indicates undervaluation relative to growth. Forward P/E 14.5x stretched relative to 1% growth. Quality metrics strong (ROE 42%, ROA 22%, margin 16%). Balance sheet: strong liquidity (2.3x). Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $22.5B |
| Beta | 1.01 |
| 52W Range | $159.25 - $423.32 |
| Short Interest | 8.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.90 |
| Forward P/E | 14.5 |
| Current P/E | 14.6 |
| YoY Growth | 0.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at 1.1% (minimal 5-day change). Below STRENGTH zone by 1.9pp (needs >3.0% for momentum thesis). MRS_5 at 0.9% confirms short-term momentum alignment. Below SMA200 (0.81x), long-term trend not supportive. MACD histogram positive (1.20), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.14% (CS: 62) | Neutral |
| RSI_14 | 62.4 | Neutral |
| MACD Histogram | 1.20 | Bullish |
| vs SMA20 | 1.064x | Above |
| vs SMA50 | 1.081x | Above |
| vs SMA200 | 0.806x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $187.62
- **Stop Loss:** $175.38 (6.5% risk)
- **Target:** $199.86 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 81
- **Position Value:** $15,197.22
- **Portfolio %:** 15.20%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with signs of improving risk appetite. Multiple major banks lowering prime rates suggest a dovish tilt in financial conditions ahead of the FOMC, while volatility remains subdued and breadth is moderate. Key drivers are easing lending rates, stable macro data, and improving sentiment, but selectivity is needed due to sector divergences.*

### Earnings

**Next:** 2025-12-11 (Est: $2.72)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.85 | $3.10 | +8.7% |
| 2025Q2 | $2.59 | $2.60 | +0.4% |
| 2025Q1 | $5.87 | $6.14 | +4.6% |
| 2024Q4 | $2.72 | $2.87 | +5.5% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*